Stratus Therapeutics
PrivateLast Round
Series A
Extension
Mar 12, 2025
Total Funding Raised
$184M
Company Overview
Stratus Therapeutics is a biotechnology company developing on-demand, off-the-shelf hematopoietic stem cell therapies for blood and immune system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stratus Therapeutics Comparables
Compare Stratus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Garuda Therapeutics | 100% | |
| Cell BioEngines, Inc. | 83% | |
| Gamida Cell Ltd. | 72% |
Stratus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 12, 2025 | ||||
| Series B | Feb 7, 2023 | ||||
| Series A | Sep 23, 2021 |
Stratus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ridgeback Capital | Series A |
| Cormorant Asset Management | Series A, Series A Extension, Series B |
| Mass General Brigham Innovation | Series B, Series A |
| OrbiMed | Series A Extension, Series B, Series A |
| Northpond Ventures | Series A Extension, Series B, Series A |
| Alexandria Venture Investments | Series B |
| Aisling Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2025
$50M round with participation from OrbiMed and others.
- Feb 7, 2023
$62M round led by Cormorant Asset Management, OrbiMed, Aisling Capital, and Northpond Ventures.
Stratus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stratus Therapeutics's valuation, stock price, and market status.
Is Stratus Therapeutics a public or private company?
Stratus Therapeutics is a private company.
What is the current stock price of Stratus Therapeutics?
Stratus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Stratus Therapeutics worth (valuation)?
Valuation information for Stratus Therapeutics is not publicly available.
Can I buy Stratus Therapeutics stock?
Stratus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Stratus Therapeutics's last funding round?
Funding round information for Stratus Therapeutics is not publicly available.
Who are the main investors in Stratus Therapeutics?
Investor information for Stratus Therapeutics is not publicly disclosed.
Will Stratus Therapeutics IPO soon?
No public IPO plans have been announced for Stratus Therapeutics.
How can I track Stratus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stratus Therapeutics's secondary market activity and sign up for updates.